OVERVIEW Protagonist Therapeutics, Inc. (referred to as Protagonist, the Company, we, our or us) is an integrated discovery and development company with a validated technology platform. Our programs fall into three broad therapeutic areas: (i) inflammation and immunology (I&I), (ii) hematology and (iii) metabolic diseases. Our aim is to develop medicines for biologically and commercially validated targets which demonstrate a strong differentiation compared to existing therapies. Our Development ...
Q2 FY2026 — expected 2026-08-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-25 | 2025-12-31 | 0001104659-26-019696 | EDGAR | 73K words |
| 2025-02-21 | 2024-12-31 | 0001558370-25-001317 | EDGAR | — |
| 2024-02-27 | 2023-12-31 | 0001558370-24-001850 | EDGAR | — |
| 2023-03-15 | 2022-12-31 | 0001558370-23-003906 | EDGAR | — |
| 2022-02-28 | 2021-12-31 | 0001558370-22-002385 | EDGAR | — |
| 2021-03-10 | 2020-12-31 | 0001558370-21-002715 | EDGAR | — |
| 2020-03-10 | 2019-12-31 | 0001558370-20-002334 | EDGAR | — |
| 2019-03-12 | 2018-12-31 | 0001558370-19-001853 | EDGAR | — |
| 2018-03-07 | 2017-12-31 | 0001558370-18-001637 | EDGAR | — |
| 2017-03-07 | 2016-12-31 | 0001193125-17-073383 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001104659-26-091123 | EDGAR | — |
| 2025-11-06 | 2025-09-30 | 0001104659-25-107816 | EDGAR | 25K words |
| 2025-08-06 | 2025-06-30 | 0001558370-25-010534 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0001558370-25-006530 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001558370-24-014888 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0001558370-24-011095 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0001558370-24-007081 | EDGAR | — |
| 2023-11-02 | 2023-09-30 | 0001558370-23-017460 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0001558370-23-013245 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0001558370-23-008137 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001558370-22-016908 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001558370-22-012277 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001104659-26-091099 | EDGAR | — |
| 2026-02-25 | 0001104659-26-019658 | EDGAR | 3K words |
| 2026-01-12 | 0001104659-26-002724 | EDGAR | — |
| 2025-11-06 | 0001104659-25-107753 | EDGAR | — |
| 2025-08-06 | 0001104659-25-074719 | EDGAR | — |
| 2025-06-26 | 0001104659-25-063038 | EDGAR | — |
| 2025-05-06 | 0001104659-25-045073 | EDGAR | — |
| 2025-03-20 | 0001104659-25-026135 | EDGAR | — |
| 2025-03-10 | 0001104659-25-021986 | EDGAR | — |
| 2025-03-03 | 0001104659-25-019516 | EDGAR | — |
175 total filings indexed. 143 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001377121 |
| Ticker | PTGX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.protagonist-inc.com |
| Listed | 2016-08-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/PTGX (~200 tokens, structured JSON with cryptographic provenance)